Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Free Cash Flow (2019 - 2025)

Bioadaptives' Free Cash Flow history spans 7 years, with the latest figure at -$155828.0 for Q4 2025.

  • Quarterly results put Free Cash Flow at -$155828.0 for Q4 2025, down 54.99% from a year ago — trailing twelve months through Dec 2025 was -$516025.0 (down 106.81% YoY), and the annual figure for FY2025 was -$534025.0, down 114.02%.
  • Free Cash Flow for Q4 2025 was -$155828.0 at Bioadaptives, down from -$151309.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$19461.0 in Q1 2023 to a low of -$155828.0 in Q4 2025.
  • The 5-year median for Free Cash Flow is -$58614.0 (2021), against an average of -$68761.2.
  • The sharpest move saw Free Cash Flow plummeted 258.98% in 2021, then soared 68.18% in 2023.
  • Year by year, Free Cash Flow stood at -$35403.0 in 2021, then grew by 22.31% to -$27504.0 in 2022, then tumbled by 231.94% to -$91296.0 in 2023, then decreased by 10.12% to -$100538.0 in 2024, then plummeted by 54.99% to -$155828.0 in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$155828.0, -$151309.0, and -$110982.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.